ArticleThe Permanente journal2015

Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.

Daniela A Bota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.